Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00430781

Femme Homme

Extrait

This study is being conducted to compare the efficacy and safety of pazopanib in combination with lapatinib with that of lapatinib alone or pazopanib alone in subjects with metastatic cervical cancer


Critère d'inclusion

  • Neoplasms, Uterine Cervix ,Metastatic Cervical Cancer


Liens